id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
676,,,,,,,,,,,,,,,2024-04-30T12:37:06+06:00,BSH - BSH - H12210294132,,Gemcitabine+ Carboplatin,2022-11-14,1.0,"Started Palliative C1D1 chemotherapy with Gemcitabine+ Carboplatin on 14.11.2022.
C6D8 completed on 11.03.2023",2024-04-20,,2024-04-20,,,,,Breast,14,Upper middle class,BSBSC-240000014,TASLIMA AKTER,1705443073,1980-10-25,Female,,,,,Dr Md Arifur Rahman,BSH,,1st Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Stable,Alive,PD,,,,,,,,,,,,,,,,,CA15.3,4.1,,2023-09-16,676.0
676,,,,,,,,,,,,,,,2024-04-30T12:37:06+06:00,BSH - BSH - H12210294132,,Gemcitabine+ Carboplatin,2022-11-14,1.0,"Started Palliative C1D1 chemotherapy with Gemcitabine+ Carboplatin on 14.11.2022.
C6D8 completed on 11.03.2023",2024-04-20,,2024-04-20,,,,,Breast,14,Upper middle class,BSBSC-240000014,TASLIMA AKTER,1705443073,1980-10-25,Female,,,,,Dr Md Arifur Rahman,BSH,,1st Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Stable,Alive,PD,,,,,,,,,,,,,,,,,CA15.3,9.7,,2023-12-23,676.0
